Jorge A. Goldstein, Ph.D. is a founder of the firm and a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. He is considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law. Among his many awards, in 2017, Jorge was inducted into LMG Life Sciences Hall of Fame. He wrote the book U.S. Biotechnology Patent Law, first published in 2016, with an eighth, updated edition published in 2023. The book guides readers in understanding case law dealing with patents in biotechnology. His new book, Patenting Life, which is a history of biotechnology told through his own and others’ intellectual property cases, will be published in late 2024 by Georgetown University Press.

He has forty-six years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, pharmaceuticals and BioFETs (biological field effect transistors).

He has handled several and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He has also been involved in inter partes reviews at the USPTO, as well as European oppositions, arbitrations in District Court, and in Appellate litigation both as counsel and expert witness. He is a multiply-accredited Certified Licensing Professional. As such, he has counseled clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions, and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements. In addition, Jorge founded the firm’s IP and Human Rights Pro Bono Practice, which was recognized as the winner of the 2015 Financial Times’ Most Innovative North American Lawyers award in the “Innovation in a Social Responsibility Project” category.

Between 2012 and 2016, Jorge was Visiting Professor of Law at the Universidad Austral in Buenos Aires, Argentina, where he taught biotech patent law in the then only WIPO-certified regional master’s IP program in Latin America.

Jorge received his J.D. from The George Washington University Law School with high honors, and his Ph.D. in chemistry from Harvard University. He earned his B.S. in chemistry from Rensselaer Polytechnic Institute.

Jorge’s achievements include:

  • Chambers & Partners USA, “Senior Statespeople – Intellectual Property: Patent Prosecution (District of Columbia)” (2024 – 2017)
  • IAM Patent 1000, “Washington, DC: Highly Recommended – Patent Prosecution; Recommended – Transactions; National – Life Sciences Patent Prosecution” (2024 – 2023)
  • Best Lawyers, “The Best Lawyers in America®” (2025 – 2008)
  • IAM Global Leaders, “Global Leader” (2024 – 2020)
  • Who’s Who Legal, “Thought Leaders USA: Patents & Life Sciences Patent Litigation” (2024 – 2023)
  • IAM Patent 1000, “Washington, DC: Highly Recommended – Patent Prosecution; Recommended – Transactions” (2022 – 2017)
  • Managing IP, “IP Star” (2024 – 2019)
  • Who’s Who Legal, “IP – Patents & Life Sciences – Patent Litigation” (2024 – 2015; 2011)
  • Super Lawyers, “Super Lawyers – Washington DC” (2024 – 2008)
  • The Best Lawyers in America, “Washington DC Biotechnology Law ‘Lawyer of the Year'” (2025; 2021; 2018; 2013)
  • Chambers & Partners USA, “Senior Statesmen – Life Sciences: IP/Patent Litigation (Nationwide)” (2019 – 2017)
  • The Legal 500, “Recommended Lawyer in Intellectual Property – Patent Prosecution: Semiconductors and Technology-Related” (2018)
  • LMG Life Sciences, “Finalist: Patent Strategy and Management Attorney of the Year – District of Columbia category” (2018 – 2017)
  • LMG Life Sciences, “Life Sciences Star” (2018 – 2012)
  • LMG Life Sciences, “Hall of Fame Inductee” (2017)
  • The Best Lawyers in America, “Washington DC Patent Law ‘Lawyer of the Year'” (2017)
  • Leaders League, “Innovation Technology & IP Rankings – Highly Recommended, Life Sciences” (2017)
  • Chambers & Partners USA, “Band 2 – Life Sciences: IP/Patent Litigation (Nationwide)” (2017 – 2007)
  • Chambers & Partners USA, “Band 2 – Intellectual Property: Patent Prosecution (District of Columbia)” (2017 – 2006)
  • National Law Journal, “IP Trailblazer and Pioneer” (2016)
  • IAM Patent 1000, “Highly Recommended Lawyer – Patent Prosecution and Transactions” (2016 – 2013)
  • Financial Times, “Most Innovative Lawyers in North America” (2015)
  • Certified Licensing Professional (2014)
  • IAM 250, “Leading Life Science Lawyer” (2010)
  • Judge for Annual Law Practice Magazine EDGE Awards (2009 – 2008)
  • Martindale AV Preeminent Peer Rating 5.0/5.0
  • The Legal 500, “Key Figure in Interferences – U.S.” (2008 – 2007)
  • Martindale Hubble Peer-Review Rating: AV
  • George Washington University Law School, “Order of the Coif” (1982)
  • Harvard University, “Excellence in Teaching of Chemistry” (1972;1974)
  • Rensselaer Polytechnic Institute, “Class of 1902 Research Prize” (1971)

  • J.D., The George Washington University Law School, with high honors
  • Ph.D., Chemistry, Harvard University
  • B.S., Chemistry, Rensselaer Polytechnic Institute

  • District of Columbia
  • U.S. Court of Appeals for the Federal Circuit
  • United States Patent & Trademark Office

  • American Association for the Advancement of Science
  • American Chemical Society
  • American Intellectual Property Law Association Biotechnology Committee
  • Biotechnology Industry Association

  • Spanish
  • French
  • German

Hosted Event

Free Intellectual Property Legal Clinic for Small Businesses

Sterne Kessler's Office, April 30, 2024 10:00 AM - 12:00 PM EDT

Speaking Engagement

2024 Reservation Economic Summit

Las Vegas, NV, Caesars Palace, March 13, 2024 11:15 AM - 12:00 PM EDT

Speaking Engagement

Policy Considerations in Evolving Areas of the Law

October 13, 2023

Speaking Engagement

2023 Focus on Pharma

Washington, DC, April 14, 2023 8:30 AM - 6:00 PM EST

Webinar

How to Use the Patent System to Benefit Indigenous and Local Communities

Virtual, November 30, 2021 10:05 AM - 10:30 AM EST

Speaking Engagement

The Role of IP in the Commercialization of Latin American Technology in the Rest of the World

Barranquilla, Colombia, November 19, 2019 8:00 AM - 10:30 AM EST

Speaking Engagement

CPIP Summer Institute

Beaver Creek, CO, July 23, 2019 12:00 AM - 11:59 PM EST

Speaking Engagement

Securing the Benefits of Traditional Cultural Expressions and Knowledge for Local Communities

Arlington, VA, George Mason University, June 19, 2018

Webinar

2018 IP Chat: Early Reports and New Ideas on Exhaustion

February 8, 2018 2:00 PM - 3:00 PM EST

Speaking Engagement

HUB of Marketing and Technology Transfer for the Americas

La Paz, Baja California Sur, Mexico, May 22, 2017

Related News & Insights

From Jorge A. Goldstein, Ph.D.

Firm News

August 23, 2024

Four Sterne Kessler Directors Recognized in Who’s Who Legal: IP 2024 Guide

Sterne, Kessler, Goldstein & Fox

In the News

August 5, 2024

VaxThera Obtains Patent for a Universal Vaccine Against COVID-19

Consultorsalud

Firm News

April 25, 2024

Eighteen Sterne Kessler Attorneys Recognized as 2024 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox

Firm News

January 3, 2024

Federal Circuit Affirms Sweet Win for Sweegen in Patent Invalidity Battle

Sterne, Kessler, Goldstein & Fox

Firm News

November 22, 2023

IAM Again Ranks Four Sterne Kessler Attorneys as Global Leaders

Sterne, Kessler, Goldstein & Fox

Firm News

October 31, 2023

Directors Sterne and Goldstein Recognized in Who’s Who Legal Thought Leaders: USA 2024 Guide

Sterne, Kessler, Goldstein & Fox

Firm News

October 2, 2023

Sterne, Kessler, Goldstein & Fox Marks Firm’s 45th Anniversary

Sterne, Kessler, Goldstein & Fox

Books and Chapters

September 8, 2023

U.S. Biotechnology Patent Law, 2023 ed.

Thomson Reuters Jorge A. Goldstein, Ph.D.

Firm News

August 11, 2023

Six Sterne Kessler Directors Ranked in Who’s Who Legal: IP 2023 Global Guide

Sterne, Kessler, Goldstein & Fox

In the News

July 31, 2023

Memories of an Old Bus Station Are Fresh for This D.C. Lawyer

The Washington Post

Firm News

July 31, 2023

Director Jorge A. Goldstein, Ph.D., Shines in Washington Post Profile

Sterne, Kessler, Goldstein & Fox

Firm News

July 6, 2023

Sterne Kessler and 14 Directors Earn Top Rankings in Managing IP’s 2023 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox

Firm News

March 28, 2023

Wands Stands Test of Time: 1988 Case Prominent in Amgen v. Sanofi SCOTUS Argument

Sterne, Kessler, Goldstein & Fox

Books and Chapters

August 31, 2022

U.S. Biotechnology Patent Law, 2022 ed.

Thomson Reuters Jorge A. Goldstein, Ph.D.

Firm News

July 26, 2022

Five Sterne Kessler Directors Named in 2022 Who’s Who Legal Guides

Sterne, Kessler, Goldstein & Fox

In the News

June 29, 2022

WTO Waiver Spurs In-House Fears of Broader Deals

Managing IP

Firm News

June 9, 2022

Sterne Kessler and D.C. Bar Pro Bono Center Host Sixth Annual Small Business Clinic

Sterne, Kessler, Goldstein & Fox

In the News

May 24, 2022

Stevia Patent Claims Fall After Sweegen Challenge

Law360

In the News

May 24, 2022

Sweegen Wins Challenges to Rival’s Artificial Sweetener Patents

Bloomberg Law

Firm News

May 1, 2022

Super Lawyers Recognizes 14 Attorneys as 2022 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox

In the News

April 18, 2022

With Billions at Stake, Supreme Court Dips Its Toes Into Biologic Drug Patents

National Law Journal

Firm News

December 1, 2021

IAM Recognizes Four Sterne Kessler Directors as 2022 Global Leaders in Intellectual Property

Sterne, Kessler, Goldstein & Fox

Books and Chapters

September 8, 2021

U.S. Biotechnology Patent Law, 2021 ed.

Thomson Reuters Jorge A. Goldstein, Ph.D.

Articles

August 17, 2021

Waiving Covid-19 Vaccine Patents Won’t Solve the Global Need

Bloomberg Law Jorge A. Goldstein, Ph.D.

Firm News

July 31, 2021

Four Sterne Kessler Directors Named in 2021 Who’s Who Legal Guides

Sterne, Kessler, Goldstein & Fox

In the News

May 4, 2021

IP Clinic Helps Protect Businesses' Intangibles

Washington Lawyer Magazine

Firm News

November 25, 2020

Directors Sterne, Goldstein, Durkin and Lee Recognized as 2021 IAM Global Leaders

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

October 8, 2020

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

September 22, 2020

Directors Sterne, Goldstein, and Pelletier Among the 2021 “Best Lawyers in America”

Sterne, Kessler, Goldstein & Fox

Books and Chapters

August 12, 2020

U.S. Biotechnology Patent Law, 2020-2021 Edition

Thomson Reuters Jorge A. Goldstein, Ph.D.

Client Alert

July 7, 2020

IP Hot Topic: Patent Prosecution Tool Kit

Carla Ji-Eun Kim

Reports

July 7, 2020

2020 Patent Prosecution Tool Kit

Sterne, Kessler, Goldstein & Fox Multiple Authors

Articles

July 7, 2020

Capturing After-Discovered Embodiments in Biotech Patents by Careful Prosecution

Sterne, Kessler, Goldstein & Fox Jorge A. Goldstein, Ph.D.

Firm News

June 16, 2020

Sterne, Kessler, Goldstein & Fox and 15 Directors Earn Top Rankings in IAM Patent 1000

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

May 5, 2020

Sterne Kessler Ranked and 13 Directors Named “IP Stars” by Managing Intellectual Property

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

April 30, 2020

Sterne, Kessler, Goldstein & Fox Attorneys Named 2020 Super Lawyers and Rising Stars

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

April 28, 2020

Pro Bono Center Continues to Serve Residents Through COVID-19

D.C. Bar

Firm News

April 24, 2020

Sterne Kessler Again Receives Sole Band 1 Chambers Ranking for Patent Prosecution Among D.C. Firms

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

April 16, 2020

Sterne Kessler Hosts Virtual Pro Bono Clinic for Small Businesses

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

April 9, 2020

Sterne Kessler Announces the Passing of Named Director Samuel L. Fox

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Books and Chapters

November 1, 2019

U.S. Biotechnology Patent Law, 2019-2020 Edition

Thomson Reuters Jorge A. Goldstein, Ph.D.

Firm News

November 1, 2019

Jorge A. Goldstein, Ph.D., Authors Fourth Edition of U.S. Biotechnology Patent Law

Sterne, Kessler, Goldstein & Fox

Books and Chapters

October 1, 2019

U.S. Chemical Patent Law: A Practical Guide

Bloomberg Law Multiple Authors

Firm News

October 1, 2019

Sterne Kessler Attorneys Author U.S. Chemical Patent Law

Sterne, Kessler, Goldstein & Fox P.L.L.C

Firm News

August 15, 2019

Directors Sterne and Goldstein Recognized in the 2020 Edition of Best Lawyers in America

Sterne, Kessler, Goldstein & Fox

Firm News

June 12, 2019

Sterne Kessler Prominent Again in Intellectual Asset Management Magazine’s "IAM Patent 1000"

Sterne, Kessler, Goldstein & Fox P.L.L.C

In the News

May 29, 2019

University Of California Gets 5th CRISPR Patent

Law360

Firm News

May 20, 2019

Sterne Kessler Tops Managing Intellectual Property’s IP Firm Rankings – Eleven Directors Named "IP Stars"

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Firm News

April 26, 2019

Sterne Kessler Snags Sole Band 1 Chambers Ranking for Patent Prosecution Among Top Washington D.C. IP Firms

Sterne, Kessler, Goldstein & Fox PLLC

Articles

February 26, 2019

Protecting Rainforest-Derived Technology Equitably

WIPO Jorge A. Goldstein, Ph.D.

Firm News

October 31, 2018

Jorge A. Goldstein, Ph.D., Authors Third Edition of U.S. Biotechnology Patent Law

Sterne, Kessler, Goldstein & Fox

Books and Chapters

October 10, 2018

U.S. Biotechnology Patent Law, 2018-2019 Edition

Thomson Reuters Jorge A. Goldstein, Ph.D.

Firm News

October 2, 2018

IP Powerhouse Sterne, Kessler, Goldstein & Fox Celebrates 40th Anniversary

Sterne, Kessler, Goldstein & Fox

Firm News

September 25, 2018

Sterne Kessler Recognized By LMG Life Sciences Among The Top IP Firms and Attorneys

Sterne, Kessler, Goldstein & Fox

In the News

August 29, 2018

Fed. Circ. Impeding Biopharma Innovation, Justices Told

Law360

Firm News

July 26, 2018

Sterne Kessler Prevails in the Release of Child from a Juvenile Detention Center

Sterne, Kessler, Goldstein & Fox

Articles

November 22, 2017

A Post-Lexmark Plan for Multiple Inventive Methods of Use

Law360 Jorge A. Goldstein, Ph.D.

Reports

June 28, 2017

2017 Patent Prosecution Tool Kit

Multiple Authors

In the News

May 4, 2017

Trump's Nafta Threats Push Mexico to Play Catchup on Innovation

Bloomberg

Articles

April 4, 2017

The State Of The IP Boutique: Part 2

Law360 Jorge A. Goldstein, Ph.D., Michael B. Ray

Articles

April 3, 2017

The State Of The IP Boutique: Part 1

Law360 Jorge A. Goldstein, Ph.D., Michael B. Ray

News

October 6, 2016

Jorge A. Goldstein, Ph.D. Authors U.S. Biotech Patent Law Book

Thomson Reuters

Articles

September 25, 2016

Is it Time To Amend 101?

IP Watchdog Jorge A. Goldstein, Ph.D., Michelle K. Holoubek

Firm News

September 14, 2016

Sterne Kessler Named IPR Firm of the Year by LMG Life Sciences

LMG Life Sciences

Articles

May 25, 2016

The Time Has Come to Amend 35 U.S.C. § 101

American Intellectual Property Law Association Quarterly Journal Jorge A. Goldstein, Ph.D., Michelle K. Holoubek

Articles

May 9, 2016

Capturing After-Discovered Embodiments in Biotechnology Patents

The Federal Circuit Bar Journal Jorge A. Goldstein, Ph.D.

In the News

January 5, 2016

5 Ways IP Attys Can Make The World Better This Year

Law360

Articles

May 29, 2015

Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement

Bloomberg BNA - Life Sciences Law & Industry Report Jorge A. Goldstein, Ph.D.

Articles

April 20, 2015

Of Isolated Genes and Covalent Bonds: A Personal Memoir of Myriad Genetics

IP Today Jorge A. Goldstein, Ph.D.

Articles

April 7, 2015

AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirement for Antibodies Gone Too Far?

Bloomberg BNA - Life Sciences Law & Industry Report Jorge A. Goldstein, Ph.D.

In the News

August 27, 2014

Legal Experts Assess Potential Impact of GeneDx's IPR Challenge of Myriad Patents

GenomeWeb’s Pharmacogenomics Reporter

In the News

August 20, 2014

Defense to Myriad Patent Infringement Claim Now Moved to Patent Trial and Appeal Board

Bloomberg BNA Patent, Trademark & Copyright Law Daily Bulletin